Recombinant Salmonella paratyphi A Probable intracellular septation protein A (yciB)

What is Salmonella enterica serovar Paratyphi A and why is it a focus of vaccine research?

Salmonella Paratyphi A is one of the primary causative agents of paratyphoid fever, with an increasing global incidence. Unlike Salmonella Typhi, which produces the immunogenic Vi capsular polysaccharide, S. Paratyphi A naturally lacks this component . Currently licensed vaccines for typhoid fever (live Ty21a vaccine, Vi subunit vaccine, and Vi-conjugate vaccine) provide inadequate cross-immunoprotection against paratyphoid fever . This has driven significant research into developing bivalent vaccines that could provide protection against both pathogens. Recent approaches include engineering S. Paratyphi A strains to express Vi polysaccharide by integrating the viaB locus, which contains 10 genes responsible for Vi biosynthesis . When combined with virulence-attenuating deletions in genes like htrA and phoPQ, these engineered strains show promise as vaccine candidates in mouse models .

What is the function of intracellular septation protein A (yciB) in bacterial cell biology?

YciB (Probable intracellular septation protein A) is a membrane protein involved in bacterial cell division and cellular envelope integrity. During septation, it contributes to proper membrane invagination and peptidoglycan synthesis at the division site. As a membrane protein, YciB likely interacts with components of both the cytoplasmic membrane and the cell wall synthesis machinery.

Methodologically, characterizing YciB function requires:

• Generation of deletion mutants using allelic exchange techniques similar to those described for virulence gene modifications in S. Paratyphi A

• Fluorescent protein fusions to visualize localization during cell division

• Protein-protein interaction studies to identify binding partners

• Phenotypic characterization of mutants under various growth conditions

• Complementation analysis with wild-type and mutant alleles

How does the Type III Secretion System (T3SS) contribute to Salmonella pathogenesis?

The Type III Secretion System (T3SS) is crucial for Salmonella virulence and functions as a molecular needle that injects effector proteins directly into host cells . Research has demonstrated that the T3SS machinery itself directly modulates the extent to which bacteria escape from phagosomes, independent of translocated effectors .

The T3SS includes:

• A needle complex spanning bacterial membranes

• Translocon components (like SipC in Salmonella) that form pores in host cell membranes

• Regulatory proteins controlling expression and assembly

• Chaperones that bind effectors in the bacterial cytoplasm

Importantly, the translocon protein component (Salmonella SipC) has been shown to determine bacterial intracellular fate within both epithelial cells and macrophages . This finding emerged from research using an innovative approach where a functional Shigella T3SS was introduced into laboratory E. coli strains, demonstrating that the T3SS apparatus itself can mediate vacuole lysis .

What genetic engineering strategies are most effective for expressing recombinant proteins in S. Paratyphi A?

Based on successful approaches for engineering S. Paratyphi A, the following methodologies are recommended:

Table 1: Comparative Genetic Engineering Approaches for S. Paratyphi A

For stable expression of membrane proteins like YciB, chromosomal integration using suicide plasmids containing:

• The yciB gene with native or inducible promoter

• Flanking homology regions for targeted integration

• Counter-selectable markers (like sacB) for selection of double recombinants

• Antibiotic resistance for initial selection

This approach has been successfully used for integrating the viaB locus into S. Paratyphi A CMCC 50093, with stable maintenance through more than 200 passages .

What challenges exist in purifying membrane proteins like YciB from Salmonella, and how can they be addressed?

Purification of membrane proteins like YciB presents specific challenges:

Table 2: Membrane Protein Purification Challenges and Solutions

A comprehensive purification protocol would include:

• Optimization of expression conditions (temperature, induction time, media composition)

• Membrane fraction isolation using differential centrifugation

• Solubilization screening to identify optimal detergent conditions

• Affinity chromatography using N- or C-terminal tags (His, FLAG, etc.)

• Secondary purification by ion exchange or size exclusion chromatography

• Functional validation using appropriate activity assays

How can researchers effectively study YciB-protein interactions in S. Paratyphi A?

Studying protein-protein interactions involving membrane proteins requires specialized approaches:

Table 3: Methods for Studying YciB Protein Interactions

For YciB specifically, researchers should:

• Generate fusion constructs with appropriate epitope tags or fluorescent proteins

• Validate function of tagged proteins (complementation of deletion phenotypes)

• Perform preliminary localization studies to identify potential interaction sites

• Use proximity-based labeling (BioID, APEX) to identify neighboring proteins

• Confirm key interactions with multiple orthogonal methods

• Assess interaction dynamics under different environmental conditions that affect Salmonella virulence, such as oxygen "sweet spots" that trigger virulence systems

How does deletion or overexpression of YciB affect S. Paratyphi A virulence and host cell interactions?

Investigating YciB's role in virulence requires systematic manipulation and phenotypic characterization:

Table 4: Experimental Design for YciB Virulence Studies

The approach should include:

• Construction of mutants using techniques similar to those used for htrA and phoPQ deletion in S. Paratyphi A

• In vitro infection models using epithelial cells and macrophages

• Comparison of phagosomal escape rates using the digitonin permeabilization and fluorescent antibody labeling method described for studying T3SS function

• Assessment of T3SS function in YciB mutants, given the importance of this system for Salmonella virulence

• Evaluation of mutant survival under relevant stress conditions, including those encountered during infection

What is the relationship between YciB function and Type III Secretion System (T3SS) efficiency?

Given the importance of T3SS in Salmonella pathogenesis , potential functional relationships with YciB deserve investigation:

• T3SS component localization: Determine if YciB affects proper localization of injectisome components using immunofluorescence or fluorescent protein fusions

• T3SS assembly kinetics: Compare assembly rates between wild-type and ΔyciB strains

• Effector translocation: Measure delivery of reporter-tagged effectors into host cells

• Host cell invasion: Compare invasion rates in epithelial cells using gentamicin protection assays

• Membrane integrity: Assess if YciB deletion affects membrane properties critical for T3SS function

Since environmental parameters like oxygen levels act as signals for Salmonella to turn virulence systems on and off , researchers should examine if YciB participates in sensing or responding to these signals, potentially affecting T3SS expression or function.

How do genomic variations in the yciB gene correlate with clinical outcomes of S. Paratyphi A infections?

This research direction would leverage genomic epidemiology approaches similar to those used in the development of Paratype, a genotyping tool for S. Paratyphi A .

Table 5: Framework for Analyzing YciB Genomic Variations

Implementation would require:

• Collection and whole-genome sequencing of diverse clinical S. Paratyphi A isolates

• Analysis using the Paratype SNP-based genotyping scheme that segregates S. Paratyphi A into three primary, nine secondary clades, and 18 genotypes

• Specific focus on yciB variations and their correlation with antimicrobial resistance markers

• In vitro characterization of identified variations through site-directed mutagenesis

• Potential incorporation of yciB sequence data into expanded genotyping schemes

Could YciB serve as a target for novel antimicrobial development against S. Paratyphi A?

Evaluating YciB as a potential antimicrobial target requires systematic assessment:

Table 6: Antimicrobial Target Evaluation Criteria for YciB

Research approaches should include:

• Determination of YciB structure through X-ray crystallography or cryo-EM

• High-throughput screening campaigns to identify inhibitory compounds

• Medicinal chemistry optimization of hit compounds

• Assessment of effects on bacterial growth, division, and virulence

• Evaluation of synergy with existing antibiotics

How might recombinant YciB be incorporated into vaccine development strategies against S. Paratyphi A?

Building on the successful approach of creating a Vi-producing attenuated S. Paratyphi A vaccine candidate , YciB could be explored as a vaccine component:

Table 7: YciB-Based Vaccine Development Strategies

Research directions should include:

• Immunogenicity screening of YciB epitopes in animal models

• Combination with established approaches like Vi polysaccharide expression

• Evaluation of htrA and phoPQ deletions (used in existing vaccine candidates ) in combination with YciB-based strategies

• Assessment of both humoral and cell-mediated immune responses

• Protection studies against wild-type challenge with both S. Paratyphi A and S. Typhi, similar to those described for the Vi-producing vaccine candidate

How do environmental conditions that Salmonella encounters during infection affect YciB expression and function?

This research question connects to findings about Salmonella's ability to sense environmental parameters that signal its location in the intestine, enabling precise timing of virulence activation .

Table 8: Environmental Factors Affecting Salmonella Virulence and Potential YciB Responses

Experimental approaches should:

• Generate reporter fusions (YciB-GFP, yciB promoter-luciferase) to monitor expression

• Expose bacteria to systematically varied environmental conditions

• Evaluate YciB localization, expression, and post-translational modifications

• Assess phenotypes of YciB mutants under these conditions

• Determine if YciB contributes to sensing the "sweet spot" conditions that Salmonella requires for activating virulence systems

What role might bacteriophage therapy targeting S. Paratyphi A have on YciB function and bacterial susceptibility?

With emerging interest in bacteriophage therapy against Salmonella , understanding phage-YciB interactions could be valuable:

• Isolation and characterization of S. Paratyphi A bacteriophages (similar to Sal11TP )

• Comparison of phage infection efficiency between wild-type and ΔyciB strains

• Identification of phage resistance mechanisms potentially involving YciB

• Evaluation of combinatorial approaches using phages and conventional antibiotics

• In vivo assessment of therapeutic potential using animal models

How does YciB contribute to antibiotic resistance mechanisms in S. Paratyphi A?

With rising antimicrobial resistance in S. Paratyphi A , YciB's potential role deserves investigation:

Table 9: Potential YciB Contributions to Antimicrobial Resistance

Research methodology should include:

• Minimum inhibitory concentration (MIC) determination for multiple antibiotics in wild-type vs. ΔyciB strains

• Transcriptomic analysis to identify resistance genes differentially expressed in YciB mutants

• Genetic interaction studies with known resistance determinants

• Evaluation of persister cell formation and antibiotic tolerance

• Correlation of specific yciB variants with antimicrobial resistance profiles in clinical isolates using approaches similar to the Paratype genotyping framework